Vivesto AB (LTS:0N4A) Transcripts

Q3 2022 Vivesto AB Earnings Call Transcript
Nov 17, 2022

kr0.461964

Earnings
Q2 2022 Vivesto AB Earnings Call Transcript
Aug 25, 2022

kr0.774223 (-2.72%)

Earnings
Q1 2022 Vivesto AB Earnings Call Transcript
May 25, 2022

kr0.749593

Earnings
Q4 2021 Oasmia Pharmaceutical AB Earnings Call Transcript
Feb 24, 2022

kr1.04 (-2.18%)

Earnings
Oasmia Pharmaceutical AB Online Presentation Transcript
Jan 19, 2022
Q3 2021 Oasmia Pharmaceutical AB Earnings Call Transcript
Nov 18, 2021

kr1.43

Earnings
Q2 2021 Oasmia Pharmaceutical AB Earnings Call Transcript
Aug 19, 2021

kr1.92

Earnings
Oasmia Pharmaceutical AB (publ) - Special Call Transcript
Mar 01, 2021
Full Year 2020 Oasmia Pharmaceutical AB Earnings Call Transcript
Feb 19, 2021

kr2.26

Earnings
Q2 2021 Oasmia Pharmaceutical AB Earnings Call Transcript
Dec 09, 2020

kr2.43 (-2.91%)

Earnings
LSK BioPartners, Inc., Oasmia Pharmaceutical AB (publ) - Special Call Transcript
Dec 03, 2020
Vivesto AB at Sachs Associates Biotech in Europe Forum (Virtual) Transcript
Sep 21, 2020
Q1 2021 Oasmia Pharmaceutical AB Earnings Call Transcript
Sep 09, 2020

kr3.27 (-0.81%)

Earnings
Q4 2020 Oasmia Pharmaceutical AB Earnings Call Transcript
Jun 18, 2020

kr4.09 (-3.86%)

Earnings

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.